Nama's AI scorecard currently rates Colgate-Palmolive Buy (6.6 out of 10), a call computed from its profitability, cash generation, growth, valuation and balance sheet. It is a research reading, not investment advice.

What is CL's P/E ratio?

Colgate-Palmolive trades at a trailing price-to-earnings ratio of 24.9.

When does CL report earnings?

Colgate-Palmolive's next scheduled report is on Jan 29, 2027. Analysts expect EPS of $0.98.

What is the CL price target?

The median analyst price target from 20 analysts is $102.50, with a range of $88.00 – $112.00.

Is CL Shariah compliant?

Nama's AAOIFI-style screen reads Colgate-Palmolive as Shariah Compliant. Passes our debt, cash and income screen; not a scholar's ruling.

Does CL pay a dividend?

Yes — Colgate-Palmolive's dividend yield is 2.2%.

Nama Insights

Colgate-Palmolive (CL)

Consumer Defensive · Household Personal Products · NYSE

S&P 500

Colgate-Palmolive (CL) is a Consumer Defensive company in the Household Personal Products industry. It has a market capitalization of $76.76B, a trailing price-to-earnings ratio of 24.9 and a free-cash-flow yield of 4.6%. Over the most recent reported fiscal year, revenue grew 1.4% and free cash flow per share grew 4.0%. Nama's AI scorecard rates it Buy, 6.6 out of 10. On 12-month momentum it ranks in the middle band of its market.

AI scorecard

Buy · 6.6/10

Positive, at the low end of Buy. As of Nov 7, 2026.

Momentum

Middle · +12.9% over 12 months ex. last

Middle fifth of its market on the past year's move.

Shariah screen

Shariah Compliant

Passes our debt, cash and income screen; not a scholar's ruling.

Off its high

-11.7%

How far the last close sits under the highest price of the past five years.

Market cap	$76.76B
Trailing P/E	24.9
Price / book	321.9
Price / sales	3.6
FCF yield	4.6%
Dividend yield	2.2%
Gross margin	60.4%
Operating margin	19.3%
Net margin	9.7%
Revenue growth (YoY)	+1.4%
Revenue growth (3-yr annual)	+4.3%
EPS growth (YoY)	+2.8%
FCF/share growth (YoY)	+4.0%
Beta	0.3
Exchange	NYSE
Sector	Consumer Defensive
Industry	Household Personal Products

CL earnings

Next report: Jan 29, 2027 (Q4 2026, EPS estimate $0.98). Beat the EPS estimate in 4 of 4 recent quarters.

Quarter	Reported	EPS	Estimate	Surprise	Revenue
Q3 2026	Oct 30, 2026	$0.97	$0.93	+4.3%	$5.37B
Q2 2026	Jul 31, 2026	$0.99	$0.95	+4.2%	$5.36B
Q1 2026	May 1, 2026	$0.97	$0.94	+3.2%	$5.32B
Q4 2025	Jan 30, 2026	$0.95	$0.91	+4.4%	$5.23B

CL analyst price target

Median target $102.50 from 20 analysts, ranging $88.00 – $112.00.

Household Personal Products peers

Ticker	Company	Market cap	P/E
PG	Procter & Gamble	$383.36B	24.0
UL	Unilever	$142.12B	44.0
KMB	Kimberly-Clark	$66.54B	14.2
EL	Estée Lauder Companies	$39.88B	37.8
KVUE	Kenvue	$37.11B	16.2
CHD	Church & Dwight	$25.81B	30.2
CLX	Clorox	$12.09B	16.0
ELF	e.l.f. Beauty	$6.86B	25.7

Explore live CL data on Nama Insights →

Recent Congressional trades

Colgate-Palmolive trades disclosed by members of the US House and Senate under the STOCK Act. See the full Congress trades board →

Member	Chamber	Trade	Amount	Disclosed
Kevin Hern	House	Sell	$1,001 - $15,000	Sep 25, 2026
Kevin Hern	House	Sell	$1,001 - $15,000	Sep 25, 2026
Kevin Hern	House	Sell	$1,001 - $15,000	Sep 25, 2026
Kevin Hern	House	Sell	$1,001 - $15,000	Sep 1, 2026
Julie Johnson	House	Sell	$1,001 - $15,000	Aug 5, 2026
Lisa McClain	House	Sell	$1,001 - $15,000	Oct 22, 2025
Rick Larsen	House	Sell	$1,001 - $15,000	Oct 16, 2025
Tim Moore	House	Sell	$1,001 - $15,000	Oct 10, 2025
Julie Johnson	House	Sell	$1,001 - $15,000	Oct 7, 2025
Lisa McClain	House	Buy	$1,001 - $15,000	Sep 12, 2025
Ritchie John Torres	House	Sell	$1,001 - $15,000	Aug 20, 2025
Lisa McClain	House	Sell	$1,001 - $15,000	Aug 13, 2025

CL FAQ

Is CL a buy?: Nama's AI scorecard currently rates Colgate-Palmolive Buy (6.6 out of 10), a call computed from its profitability, cash generation, growth, valuation and balance sheet. It is a research reading, not investment advice.
What is CL's P/E ratio?: Colgate-Palmolive trades at a trailing price-to-earnings ratio of 24.9.
When does CL report earnings?: Colgate-Palmolive's next scheduled report is on Jan 29, 2027. Analysts expect EPS of $0.98.
What is the CL price target?: The median analyst price target from 20 analysts is $102.50, with a range of $88.00 – $112.00.
Is CL Shariah compliant?: Nama's AAOIFI-style screen reads Colgate-Palmolive as Shariah Compliant. Passes our debt, cash and income screen; not a scholar's ruling.
Does CL pay a dividend?: Yes — Colgate-Palmolive's dividend yield is 2.2%.